190 related articles for article (PubMed ID: 16083339)
1. Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges.
Hu E; Lee D
Expert Opin Ther Targets; 2005 Aug; 9(4):715-36. PubMed ID: 16083339
[TBL] [Abstract][Full Text] [Related]
2. Rho kinase inhibitors as potential therapeutic agents for cardiovascular diseases.
Hu E; Lee D
Curr Opin Investig Drugs; 2003 Sep; 4(9):1065-75. PubMed ID: 14582450
[TBL] [Abstract][Full Text] [Related]
3. Small guanine nucleotide-binding protein Rho and myocardial function.
Ren J; Fang CX
Acta Pharmacol Sin; 2005 Mar; 26(3):279-85. PubMed ID: 15715922
[TBL] [Abstract][Full Text] [Related]
4. ROCKs as therapeutic targets in cardiovascular diseases.
Rikitake Y; Liao JK
Expert Rev Cardiovasc Ther; 2005 May; 3(3):441-51. PubMed ID: 15889972
[TBL] [Abstract][Full Text] [Related]
5. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine.
Shimokawa H; Satoh K
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1756-69. PubMed ID: 26069233
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.
Dong M; Yan BP; Liao JK; Lam YY; Yip GW; Yu CM
Drug Discov Today; 2010 Aug; 15(15-16):622-9. PubMed ID: 20601092
[TBL] [Abstract][Full Text] [Related]
7. Targeting Rho and Rho-kinase in the treatment of cardiovascular disease.
Budzyn K; Marley PD; Sobey CG
Trends Pharmacol Sci; 2006 Feb; 27(2):97-104. PubMed ID: 16376997
[TBL] [Abstract][Full Text] [Related]
8. Cellular regulation of basal tone in internal anal sphincter smooth muscle by RhoA/ROCK.
Patel CA; Rattan S
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1747-56. PubMed ID: 17379756
[TBL] [Abstract][Full Text] [Related]
9. Progress of the study of rho-kinase and future perspective of the inhibitor.
Tawara S; Shimokawa H
Yakugaku Zasshi; 2007 Mar; 127(3):501-14. PubMed ID: 17329936
[TBL] [Abstract][Full Text] [Related]
10. Rho-kinase inhibition in the therapy of cardiovascular disease.
Lai A; Frishman WH
Cardiol Rev; 2005; 13(6):285-92. PubMed ID: 16230885
[TBL] [Abstract][Full Text] [Related]
11. Rho kinases in cardiovascular physiology and pathophysiology.
Loirand G; Guérin P; Pacaud P
Circ Res; 2006 Feb; 98(3):322-34. PubMed ID: 16484628
[TBL] [Abstract][Full Text] [Related]
12. Rho kinase in the regulation of cell death and survival.
Shi J; Wei L
Arch Immunol Ther Exp (Warsz); 2007; 55(2):61-75. PubMed ID: 17347801
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of small GTPase Rho in cardiovascular diseases].
Kawano Y; Yoshimura T; Kaibuchi K
Nihon Yakurigaku Zasshi; 2002 Sep; 120(3):149-58. PubMed ID: 12271510
[TBL] [Abstract][Full Text] [Related]
14. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
15. Rho-kinase is an important therapeutic target in cardiovascular medicine.
Shimokawa H; Takeshita A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
[TBL] [Abstract][Full Text] [Related]
16. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
[TBL] [Abstract][Full Text] [Related]
17. Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.
Shi J; Wei L
J Cardiovasc Pharmacol; 2013 Oct; 62(4):341-54. PubMed ID: 23921309
[TBL] [Abstract][Full Text] [Related]
18. Physiological role of ROCKs in the cardiovascular system.
Noma K; Oyama N; Liao JK
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C661-8. PubMed ID: 16469861
[TBL] [Abstract][Full Text] [Related]
19. Rho-kinase: important new therapeutic target in cardiovascular diseases.
Satoh K; Fukumoto Y; Shimokawa H
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H287-96. PubMed ID: 21622831
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells.
Xie Z; Su W; Guo Z; Pang H; Post SR; Gong MC
Cardiovasc Res; 2006 Feb; 69(2):491-501. PubMed ID: 16336954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
